Pluri (PLUR) Other financing activities (2013 - 2025)
Pluri (PLUR) reported Other financing activities of $763000.0 for Q4 2025, up 198.05% year-over-year from $256000.0 in Q4 2024, and down 43.48% quarter-over-quarter from $1.3 million in Q3 2025.
Pluri (PLUR) Other financing activities (2013 - 2025) Analysis & Trends
Pluri (PLUR) has 13 years of Other financing activities data on file, last reported at $763000.0 in Q4 2025.
- Other financing activities for Q4 2025 came in at $763000.0, up 198.05% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.4 million (down 57.79% YoY), and the FY2025 annual result was $2.1 million, down 75.51% from the prior year.
- Other financing activities fell to $763000.0 in Q4 2025 per PLUR's latest filing, from $1.3 million in the prior quarter.
- Over five years, Other financing activities peaked at $6.7 million in Q2 2024 and troughed at $256000.0 in Q4 2024.
- A 5-year average of $1.8 million and a median of $1.0 million in 2022 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2021 and 2025: Other financing activities jumped 1389.22% in 2021, then plunged 87.54% in 2025.
- A 5-year view of Other financing activities shows it stood at $1.9 million in 2021, then slumped by 51.25% to $913000.0 in 2022, then tumbled by 37.24% to $573000.0 in 2023, then tumbled by 55.32% to $256000.0 in 2024, then jumped by 198.05% to $763000.0 in 2025.
- Business Quant data shows PLUR's Other financing activities at $763000.0 in Q4 2025, $1.3 million in Q3 2025, and $838000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 763,000.00 |
| Dec 31, 2025 | 763,000.00 |
| Sep 30, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 838,000.00 |
| Jun 30, 2025 | 838,000.00 |
| Mar 31, 2025 | 491,000.00 |
| Mar 31, 2025 | 491,000.00 |
| Dec 31, 2024 | 256,000.00 |
| Dec 31, 2024 | 256,000.00 |
| Sep 30, 2024 | 558,000.00 |
| Sep 30, 2024 | 558,000.00 |
| Jun 30, 2024 | 6.72 Mn |
| Jun 30, 2024 | 6.72 Mn |
| Mar 31, 2024 | 618,000.00 |
| Mar 31, 2024 | 618,000.00 |
| Dec 31, 2023 | 573,000.00 |
| Dec 31, 2023 | 573,000.00 |
| Sep 30, 2023 | 836,000.00 |
| Sep 30, 2023 | 836,000.00 |